Last reviewed: July 2, 2026
Last updated: July 2, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic (semaglutide) has gained prominence for weight management, yet not everyone qualifies for this medication. PlexusDx evaluates patient candidacy through clinical criteria including BMI thresholds, metabolic health markers, and absence of contraindications—ensuring safe, personalized treatment pathways for eligible individuals seeking sustainable weight reduction.
Core Eligibility Requirements for Semaglutide Weight Loss
Semaglutide weight loss treatment typically requires a body mass index (BMI) of 30 or higher, or a BMI of 27 or above with at least one weight-related condition such as hypertension or type 2 diabetes. Medical professionals also assess metabolic factors, current medication interactions, and baseline kidney and thyroid function before initiating therapy. PlexusDx practitioners review comprehensive health histories to confirm suitability and rule out contraindications that could compromise safety.
Age considerations matter in eligibility screening. Adults aged 18 and older generally qualify if other criteria are met, though individual health circumstances may warrant additional evaluation. Pregnancy status and plans for conception require discussion, as semaglutide use during pregnancy is not recommended. PlexusDx consultations address these life-stage factors during the qualification process.
Medical Conditions That May Affect Your Candidacy
Certain endocrine and gastrointestinal conditions influence semaglutide eligibility. A personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) constitutes an absolute contraindication due to safety concerns documented in clinical trials. Similarly, individuals with active pancreatitis or severe gastrointestinal motility disorders may require alternative approaches or closer monitoring during treatment.
Type 2 diabetes patients often show strong candidacy, as semaglutide simultaneously addresses glycemic control and weight reduction. However, those on insulin therapy need dose adjustments and heightened glucose monitoring to prevent hypoglycemia. PlexusDx integrates metabolic history into personalized protocols, ensuring medication combinations align with existing diabetes management strategies.
Medication Interactions and Polymedication Considerations
Semaglutide interacts with certain medications, particularly those dependent on rapid gastric absorption such as oral contraceptives or specific cardiovascular agents. Delayed gastric emptying—a known semaglutide effect—can reduce bioavailability of medications requiring consistent timing. PlexusDx practitioners conduct thorough medication reviews to identify potential conflicts and adjust administration schedules or explore alternative formulations when necessary.
Patients taking GLP-1 receptor agonists, insulin, or sulfonylureas require close glucose monitoring and potential dose reductions to prevent dangerous hypoglycemic episodes. Diuretics and certain blood pressure medications may need adjustment as weight loss progresses and cardiovascular hemodynamics shift. PlexusDx coordinates with primary care providers to ensure cohesive medication management throughout treatment.
How PlexusDx Evaluates Your Personalized Eligibility and Treatment Plan
PlexusDx uses a structured assessment process combining clinical questionnaires, vital sign evaluation, and laboratory screening to determine candidacy for compounded semaglutide injections. The Precision Peptide Genetic Test—available as an add-on after the first month of treatment—identifies genetic variants in GLP1R, GIPR, FTO, and MC4R pathways that predict individual metabolic response and personalize dosing strategy. This genetic insight helps maximize efficacy while minimizing unwanted side effects across the 14 metabolic pathways PlexusDx analyzes.
Once eligibility is confirmed, PlexusDx prescribers establish a customized protocol that addresses your specific metabolic profile, lifestyle factors, and treatment goals. Compounded semaglutide injections begin at $149 per month with no insurance requirement, and pricing remains flat regardless of dose adjustments—ensuring cost predictability as your therapy optimizes. Monthly follow-up visits track progress, tolerability, and metabolic markers to refine treatment continuously.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What BMI do I need to qualify for semaglutide weight loss treatment?
Generally, a BMI of 30 or higher qualifies, or a BMI of 27 with weight-related conditions like hypertension or type 2 diabetes. PlexusDx practitioners assess your individual metabolic profile and health history to confirm candidacy, as eligibility extends beyond BMI alone to include metabolic readiness and absence of contraindications.
Can I take semaglutide if I have type 2 diabetes?
Yes—patients with type 2 diabetes often show strong candidacy because semaglutide improves both blood sugar control and body weight. However, you may need dose adjustments to insulin or other diabetes medications and require frequent glucose monitoring to prevent hypoglycemia. PlexusDx coordinates with your primary care provider to ensure safe integration with your diabetes management plan.
Is a family history of thyroid cancer a reason I cannot take semaglutide?
A personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2) is an absolute contraindication—semaglutide is not appropriate in these cases. PlexusDx screens for this during the eligibility assessment and will recommend alternative weight management strategies if needed.
How much does PlexusDx compounded semaglutide cost, and does the price change with my dose?
PlexusDx compounded semaglutide injections start at $149 per month with flat pricing regardless of dose level. Your dose may need to go up as treatment progresses, but your price won't—ensuring budget predictability. The medication is available across all 50 states with no insurance required and is HSA/FSA eligible.
What does the PlexusDx Precision Peptide Genetic Test reveal about my semaglutide response?
The Precision Peptide Genetic Test analyzes genetic variants in GLP1R, GIPR, FTO, and MC4R pathways across 14 metabolic systems and 49 peptides to predict your individual response to semaglutide therapy. These insights help PlexusDx practitioners personalize your dosing strategy and identify which metabolic mechanisms may drive your weight loss, maximizing treatment efficacy and tolerability. The test is available as a $99 add-on after your first month of treatment.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Mastering Your Weight Loss Journey: A Deep Dive into How the Ozempic® Pen Works
How Much Weight Per Week Do You Lose on Zepbound?